Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Hes-6, an Inhibitor of Hes-1, Is Regulated by 17-Beta-Estradiol and Promotes Breast Cancer Cell Prol
Link ID 23902
Title Hes-6, an Inhibitor of Hes-1, Is Regulated by 17-Beta-Estradiol and Promotes Breast Cancer Cell Prol
Url http://www.medscape.com/viewarticle/715709?src=rss
Description This study examined the function of Hes-6 in breast cancer and tested the hypothesis that Hes-6 enhances breast cancer cell proliferation and is regulated by estrogen (E2). Breast Cancer Research
Category Articles > Hematology-Oncology
Keywords
Date Apr 1, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. NF-kappaB as a Prognostic Marker and Therapeutic Target in Chronic Lymphocytic Leukemia
  This article discusses the importance of constitutive and inducible DNA binding of the transcription factor NF-kappaB in chronic lymphocytic leukemia. Future Oncology
Category:   Articles > Hematology-Oncology


2. Risk for Thyroid Cancer Persists Decades After Childhood Radiation
  Children who were exposed to radiation of the head and neck have an increased risk for thyroid cancer that lasts well into late adulthood. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Ovarian Cancer: New Treatment OptionsOvarian Cancer: New Treatment Options
  Bevacizumab, already changing clinical practice in ovarian cancer, is soon to be joined by several promising treatment options, as reported by Dr. Stanley Kaye from EMCC. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Erythropoietin Can Influence Pathologic Proliferation of Blood Vessels, Possibly Influencing Tumor G
  In addition to stimulating the formation of erythrocytes, erythropoietin can enhance pathologic proliferation of blood vessel, and could affect patients with cancer and other conditions related to abnormal blood vessel growth. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Circulating Endothelial Cells and Endothelial Progenitors as Predictive Markers of Clinical Response
  Can these biomarkers provide an early predictor of advanced CRC treatment success with bevacizumab? Annals of Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS